J&J's Stelara succeeds in chronic bowel disease study
Tuesday, October 9, 2018 - 07:50
in Health & Medicine
Johnson & Johnson said on Tuesday its blockbuster drug Stelara was found to be effective in treating a chronic bowel disease in a late-stage trial.